Background: There is a disproportionate burden of hypertension in African-Americans and less than 30% of African-Americans achieve blood pressure control with medications. Regulation of adipose tissue may represent an important link between increased insulin resistance, hypertension, and obesity, all key factors in the metabolic syndrome. Inflammation is involved in multiple stages of the development of atherosclerosis and serum levels of inflammatory markers including sVCAM-1 and sIL-6 may be used to predict cardiovascular disease risk. Nebivolol is a highly cardioselective vasodilatory beta1 receptor blocker that lowers blood pressure. We sought to determine whether nebivolol has beneficial effects on vascular markers of inflammation and oxidation in obese African-American patients with hypertension when exposed to exercise-induced stress.
